| TDGF1 | Teratocarcinoma-derived growth factor 1 |
| ceRNA | Competing endogenous RNA |
| COAD | Colon adenocarcinoma |
| EMT | Epithelial to mesenchymal transition |
| OS | Overall survival |
| DFS | Disease-free survival |
| ncRNAs | Noncoding RNAs |
| miRNAs | microRNAs |
| lncRNAs | Long noncoding RNAs |
| TIME | Tumor immune microenvironment |
| scRNA-seq | Single-cell RNA sequencing |
| TCGA | The Cancer Genome Atlas |
| TPM | Transcripts per million |
| ROC | Receiver operating characteristic |
| AUC | Area under the curve |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| GO_BP | Gene Ontology biological process |
| GSEA | Gene set enrichment analysis |
| DEGs | Differentially expressed genes |
| PPI | Protein–protein interaction |
| wt | Wild-type |
| mut | Mutant |
| qRT-PCR | Quantitative real-time PCR |
| ECL | Enhanced chemiluminescence |
| IHC | Immunohistochemistry |
| SD | Standard deviation |
| HRs | Hazard ratios |
| CIs | Confidence intervals |
| sCNAs | Somatic copy number alterations |
| circRNAs | Circular RNAs |